A phase II multicenter evaluation of several candidate pertussis vaccines in infants.
Klein
D L
DL
National Institute of Allergy and Infectious Diseases, N.I.H. Bethesda, MD 20892.
D000907:Antibodies, Bacterial / Q000097:blood; D002985:Clinical Protocols; D004311:Double-Blind Method; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D010567:Pertussis Vaccine / Q000009:adverse effects / Q000276:immunology / Q000494:pharmacology*
D000907:Antibodies, Bacterial; D010567:Pertussis Vaccine